72.34
전일 마감가:
$73.28
열려 있는:
$73.24
하루 거래량:
436.61K
Relative Volume:
0.46
시가총액:
$12.52B
수익:
$8.31B
순이익/손실:
$379.00M
주가수익비율:
33.49
EPS:
2.16
순현금흐름:
$385.00M
1주 성능:
-2.34%
1개월 성능:
-1.67%
6개월 성능:
-2.27%
1년 성능:
+32.49%
Solventum Corp Stock (SOLV) Company Profile
명칭
Solventum Corp
전화
651-733-1110
주소
C/O 3M COMPANY, ST. PAUL
SOLV을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
SOLV
Solventum Corp
|
72.34 | 12.82B | 8.31B | 379.00M | 385.00M | 2.16 |
![]()
ISRG
Intuitive Surgical Inc
|
516.12 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
175.33 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
87.16 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
261.07 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
210.08 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2025-07-01 | 업그레이드 | Argus | Hold → Buy |
2025-06-06 | 개시 | KeyBanc Capital Markets | Sector Weight |
2025-05-19 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2024-12-04 | 개시 | Mizuho | Neutral |
2024-10-08 | 개시 | Stifel | Buy |
2024-10-07 | 개시 | Piper Sandler | Neutral |
2024-09-26 | 개시 | Wolfe Research | Peer Perform |
2024-09-05 | 개시 | BTIG Research | Neutral |
2024-06-24 | 개시 | Argus | Hold |
2024-05-30 | 개시 | Goldman | Sell |
2024-05-10 | 개시 | BofA Securities | Neutral |
2024-04-10 | 개시 | Morgan Stanley | Equal-Weight |
2024-04-08 | 개시 | Wells Fargo | Equal Weight |
2024-04-02 | 개시 | Edward Jones | Hold |
모두보기
Solventum Corp 주식(SOLV)의 최신 뉴스
Solventum Corporation Stock Analysis and ForecastHigh-performance investment picks - PrintWeekIndia
What analysts say about Solventum Corporation stockExponential return rates - Autocar Professional
Is Solventum Corporation a good long term investmentFree Real-Time Stock Data - Jammu Links News
As more Minnesota companies rethink remote work, Solventum and others hold the line on flexibility - Star Tribune
Steris, Solventum upgraded, RxSight downgraded in Morgan Stanley's MedTech review - MSN
Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025 - The Malaysian Reserve
Solventum To Report Second Quarter Fiscal 2025 Earnings On August 7, 2025 - Barchart.com
Steris, Solventum stocks upgraded at Morgan Stanley (STE:NYSE) - Seeking Alpha
Morgan Stanley upgrades Solventum stock rating to Overweight on margin potential By Investing.com - Investing.com South Africa
Morgan Stanley upgrades Solventum stock rating to Overweight on margin potential - Investing.com India
Morgan Stanley Upgrades Solventum to Overweight From Equalweight, Adjusts PT to $103 From $80 - MarketScreener
Thermo Fisher Wins EU Approval for Acquisition of Solventum's Filtration Business - MarketScreener
European Commission OKs Thermo Fisher's Purchase of Solventum's Purification, Filtration Arm - MarketScreener
Solventum Launches Two Dental Innovations in Thailand - MSN
Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know - MSN
Markets | American Financial Group, Inc. - FinancialContent
Solventum Corp. Stock Falls Tuesday, Underperforms Market - 富途牛牛
Solventum Corp (SOLV) Upgraded to a ‘Buy’ at Argus Research - Insider Monkey
Solventum (NYSE:SOLV) Has A Somewhat Strained Balance Sheet - simplywall.st
Is the Options Market Predicting a Spike in Solventum Stock? - MSN
Discussing the removal of dissolved gases from water with Solventum - watertechonline.com
Solventum Amends Thermo Fisher Deal, Retains Water Filtration Business - MSN
How Is Solventum's Stock Performance Compared to Other Health Care Equipment Stocks? - MSN
Solventum (NYSE:SOLV) Stock Rating Upgraded by Argus - MarketBeat
Solventum Shows Market Leadership With Jump To 83 RS Rating - Investor's Business Daily
Solventum's Strategic Shift Sparks Analyst Optimism Amid Diverging Price Targets - AInvest
Solventum Shares Rise After Argus Research Upgrade - MarketScreener
Argus Research Upgrades Solventum to Buy From Hold, $90 Price Target - MarketScreener
5 Must-Read Analyst Questions From Solventum’s Q1 Earnings Call - Yahoo Finance
How Is Solventum's Stock Performance Compared To Other Health Care Equipment Stocks? - Barchart.com
Bryan C. Hanson - Walgreens Boots Alliance
Solventum Named a Best Company to Work for by U.S. News & World Report - GuruFocus
How Did Solventum Corporation's (NYSE:SOLV) 12% ROE Fare Against The Industry? - Yahoo Finance
With 68% ownership, Solventum Corporation (NYSE:SOLV) boasts of strong institutional backing - simplywall.st
SOLV Q1 Earnings Call: Margin Headwinds Offset by Volume Growth and Product Momentum - Yahoo Finance
Solventum Launches Preassembled, See-through VH2O2 Test Pack for Low-temp Medical Instrument Sterilization - PR Newswire
Legacy and innovation on show as Solventum unveils new products - Dentistry UK
Keybanc Initiates Coverage of Solventum (BIT:1SOLV) with Sector Weight Recommendation - Nasdaq
Q1 Rundown: Solventum (NYSE:SOLV) Vs Other Surgical Equipment & ConsumablesDiversified Stocks - MSN
Keybanc Initiates Coverage of Solventum (SOLV) with Sector Weight Recommendation - Nasdaq
Keybanc Initiates Coverage of Solventum (LSE:0AD1) with Sector Weight Recommendation - Nasdaq
KeyBanc Initiates Solventum at Sector Weight - MarketScreener
Solventum initiated with a Sector Weight at KeyBanc - TipRanks
KeyBanc initiates Solventum stock with Sector Weight rating - Investing.com India
KeyBanc initiates Solventum stock with Sector Weight rating By Investing.com - Investing.com South Africa
Solventum Corp (SOLV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):